Suppression of immune regulatory cells with combined therapy of celecoxib and sunitinib in renal cell carcinoma | |
Zhao, Qi; Guo, Jianming; Wang, Guomin; Chu, Yiwei; Hu, Xiaoyi | |
刊名 | ONCOTARGET
![]() |
2017 | |
卷号 | 8期号:1 |
关键词 | tyrosine kinase inhibitor renal cell carcinoma cyclooxygenase-2 inhibitor myeloid-derived suppressor cell regulatory T cell |
ISSN号 | 1949-2553 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3620521 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Zhao, Qi,Guo, Jianming,Wang, Guomin,et al. Suppression of immune regulatory cells with combined therapy of celecoxib and sunitinib in renal cell carcinoma[J]. ONCOTARGET,2017,8(1). |
APA | Zhao, Qi,Guo, Jianming,Wang, Guomin,Chu, Yiwei,&Hu, Xiaoyi.(2017).Suppression of immune regulatory cells with combined therapy of celecoxib and sunitinib in renal cell carcinoma.ONCOTARGET,8(1). |
MLA | Zhao, Qi,et al."Suppression of immune regulatory cells with combined therapy of celecoxib and sunitinib in renal cell carcinoma".ONCOTARGET 8.1(2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论